Modern #3 – Cytokind

Dr. Carmen Castilla Appears on WABC Radio's Bernie and Sid in the Morning To Discuss Covid Trial

LATEST RESEARCH UPDATE

Photo-Protection Trial (NB-UVB vs. Placebo) in High-risk Hospitalized COVID-19 Patients

 The purpose of this study to evaluate the translational application of the safe and effective treatment of Narrow-Band Ultraviolet light B-band (NB-UVB) to high-risk COVID-19 patients in an effort to improve their immune and hemostatic imbalance to increase survival and improve outcomes.

LEARN MORE

ARTICLES

COVID Results

MS Results

THE TEAM

LEADERS IN UVB LIGHT RESEARCH AND ASSOCIATED BLOOD ANALYSIS TO TREAT IMMUNE DISORDERS

Cytokind’s team includes pre-eminent scientific innovators, entrepreneurs, world-class researchers, and drug discovery visionaries from Stanford, MIT, Mt. Sinai, Australia, Austria, Scotland, Germany, Louisiana, Texas, and Wisconsin who are leaders in UVB light research and associated blood analysis to treat immune disorders.

These esteemed thinkers and innovators will help us on our path to discover new methods of treatment and drug discovery to address the critical needs of patients in the US and around the world.

Management

Scientific Advisors

Strategic Advisory 

TED TALK

Could the Sun Be Good For Your Heart?

To watch a more recent presentation from Dr. Weller at a Global Dermatology Talk at Yale University on 5-9-22, click here.

PHOTO-IMMUNOLOGY

EFFICACY OF PHOTO-IMMUNOLOGY

Photo-Immunology has been a leading treatment for 3 major auto-immune diseases: lupus vulgaris (a type of TB), psoriasis, and Graft versus Host Disease (GvHD). The cytokine storm in COVID-19 is very similar to the one in GvHD and provides us cautious enthusiasm for its immediate use and potential benefit.

Photo-Immunology therapy has limited clinical risk and has been saving the lives of leukemia patients with GvHD for more than 20-years and it is effective in over 50% of patients*. It is FDA-cleared for other indications and is located at clinical centers throughout the world. A single Photo-Immunology therapy unit can treat 50 patients a day every day. Treatments last less than 5 minutes.*

To learn more, see ”How it Works: The Immunology Underlying Phototherapy” By Professor Peter Wolf and other evidence below.

0%

Effective in over 50% of patients

EDUCATIONAL & RESOURCES

FACTS ABOUT UV LIGHT

UV Light & Our Biology

The impact of UV Light on our biology is so important that it is broken into 3 distinct spectrums (UVA, UVB and UVC).

UVB

We are focused on the immune-modulating properties of UVB.

UVB & Our Immune System

The effects UVB on the immune system are robust and initiated by activation of the vitamin D receptor primarily on monocytes, macrophages and dendritic cells (DCs).

LEARN MORE

UVB and Vitamin D Pathway

UVB provides 90% of the serum Vitamin D which is fundamental to a healthy immune system

COVID-19 Mortality Rates

Vitamin D Deficiency in European Countries is correlated to COVID-19 Mortality Rates

LEARN MORE

The Skin Cancer vs. Vitamin D Dilemma

Use of Sunblock reduces Immune Strength

LEARN MORE

UVB Treatment ≠ to Melenoma

"Multiple studies specifically assessing the carcinogenic potential of NB-UVB did not find an increased risk of skin cancer in treated patients. Unfortunately, there are few prospective studies assessing the risk of skin cancer in patients with psoriasis treated with NB-UVB. Because of the theoretical possibility of this risk, physicians should use caution in prescribing NB-UVB for patients with a history of melanoma, multiple nonmelanoma skin cancers, arsenic intake, or exposure to ionizing radiation." From The Joint American American Academy of Dermatology 2019

LEARN MORE

UVB Stabilizes Our Immune System

Our Immune system hungers for UV light - "Following exposure of humans to sunlight to phototherapy, there are alterations in the number, phenotype and function of circulating blood cells."

LEARN MORE